OTHER VASCULAR RISK FACTORS IN A HYPERTENSION OUTPATIENT CLINIC – 5 YEAR SERIES (2014 TO 2018) OF A HOSPITAL UNIT
DOI:
https://doi.org/10.58043/rphrc.39Keywords:
hypertension, vascular risk factors, vascular diseaseAbstract
Introduction: According to the latest recommendations by The European Society of Hypertension, the evaluation of Arterial Hypertension (AHT) is no longer based only on Blood Pressure (BP), but also takes into account other vascular risk factors. Objective: The goal of this study is to evaluate the importance of the main vascular risk factors on patients with AHT. These patients are followed through Internal Medicine outpatient clinic (AHT outpatient clinic) of a Hospital Unit.
Methods: Retrospective study based on clinical process of each patient with ATH diagnose, between the years of 2014 to 2018. These patients are followed through Internal Medicine outpatient clinic (AHT outpatient clinic) of a Hospital Unit.
Results: The total sample of this study was 318 patientes diagnoses with hypertension, being the female gender the most affected (66%, n=211), when compared to the male sex (34%, n=107). The average age is 65 years old (sd = 16,3), with the age group most affected from 65 to 84 years old with 42% of patients. The most prevalent vascular risk factors in this group of patients are obesity and dyslipidemia, with an incidence of 63% (n=200) and 61% (n=195), respectively. In regards to obesity, most of the patients are categorised with weight-excess (29%, n=93), and only 4% (n=13) of the patients are considered morbid obese, with a Body Mass Index > 40. Around 34% (n=109) of the patients with dyslipidemia are classified with hypercholesterolemia, while 22% (n=69) of the patients have mixed dyslipidemia. Refer 22% (n=70) of patients with diabetic pathology and 25% (n=79) of patients with hyperuricemia. As an important note, only 11% (n=34) of the patients show ATH as the only vascular risk factor.
Discussion/Conclusion: This study allowed a deeper knowledge concerning the vascular risk factors in patients followed through Internal Medicine outpatient clinic (AHT outpatient clinic) of a Hospital Unit. This represents a great advantage, since the recognition of these risk factos, to which we should be more and more aware, allows us a greater therapeutic assertiveness, insisting on their primary prevention effectively.
Downloads
References
Tu JV. Reducing the global burden of stroke: INTERSTROKE. Lancet, 376 (2010), pp. 74-75
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990‐2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1659‐1724. doi: 10.1016/S0140‐6736(16)31679‐8.
Rocha E. The global burden of disease: an information resource for policy‐making and evaluation of health interventions. Rev Port Cardiol., 36 (2017), pp. 283-285
Direção‐Geral da Saúde. Direção de Serviços de Informação e Análise. A Saúde dos Portugueses 2016. Lisboa: DGS, 2017.
Kannel WB et al. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens., 13 (2000), pp. 3S-10S.
Wermelt, J.A., Schunkert, H. Management der arteriellen Hypertonie. Herz 42, 515–526 (2017). https://doi.org/10.1007/ s00059-017-4574-1.
Polonia J, Martins L, Pinto F, Nazaré J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade.The PHYSA study. J Hypertens 32:1211– 1221.
Gomes, A., Coelho, P., & Pereira, A. (2012). Prevalência de
Hipertensão Arterial na população adulta do concelho da Covilhã. Sociedade Portuguesa de Hipertensão, 32, 6-16.
A.Laucevičius,E.Rinkūnienė,Z.Petrulionienė,et al.Prevalence of high‐risk profile in middle‐aged subjects with arterial hypertension: a nationwide survey. Blood Press., 23 (2014), pp. 281-287.
G. Mancia, R. Fagard, K. Narkiewicz. et al., 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens., 31 (2013 Jul), pp. 1281-1357.
Marques da Silva P, Lima M.J, Neves P, Macedo M. Prevalência de fatores de risco cardiovascular e outras comorbilidades em doentes com hipertensão arterial assistidos nos cuidados de saúde primários: estudo Precise. Rev Port Cardiol.(2019);38(6):427-437.
M.F. Piepoli, A.W. Hoes, S. Agewall, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J., 37 (2016), pp. 2315-2381.
D. Cooney, K. Pascuzzi. Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension. Clin Geriatr Med, 25 (2009), pp. 221-233.
